Star Imaging And Path Lab P/E Ratio
Current P/E Ratio
5.3
Low Valuation
Very Low - Potentially undervalued or facing challenges
Star Imaging And Path Lab P/E ratio. Star Imaging And Path Lab (STARIMAGIN) P/E ratio is 5.3 (Low), EPS (TTM) ₹11.05, current price ₹ on None — Very Low - Potentially undervalued or facing challenges. Also explore STARIMAGIN price movement history to track price trends across different timeframes.
Current Valuation Metrics
P/E Ratio
5.3
Current Price
₹
EPS (TTM)
₹11.05
Exchange
None
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
52.4
Sector Median
29.6
Sector Rank
#9 of 255
Sector Percentile
3.5%
STARIMAGIN P/E Ratio — Valuation Signal & Historical Context
Star Imaging And Path Lab P/E 5.3 — signal: Undervalued. For live price, revenue and the complete fundamental profile, see Star Imaging And Path Lab screener.
- Stock appears undervalued with PE of 5.3, suggesting potential buying opportunity
- Trading at discount to sector average PE of 52.4
STARIMAGIN vs Healthcare Peers — P/E Ratio Comparison
Star Imaging And Path Lab P/E 5.3 vs Healthcare average 52.4, median 29.6 — range 2.0–733.0.
Sector Average
52.4
Sector Median
29.6
Lowest P/E
2.0
Highest P/E
733.0
Companies
255
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.0 | ₹72 | Low |
| Brooks Laboratories | BROOKS | 2.6 | ₹206 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.3 | ₹54 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.1 | ₹6,355 | Low |
| Dipna Pharmachem | DPL | 4.5 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 4.7 | ₹82 | Low |
| Royal Sense | ROYAL | 4.8 | ₹34 | Low |
| Kabra Drugs | KABRADG | 6.3 | ₹49 | Low |
| Colinz Laboratories | COLINZ | 6.5 | ₹17 | Low |